Table 2.
First Author and Year of Publication | Study Design and Data Collection Approach, Sample Size and Sex of Participants | Prevalence of Use of T&CM and Disclosure of Use to HCP | Types of T&CM Used# | Reasons for Using T&CM | Characteristics of Users Significantly Associated with T&CM Use | Reported Satisfaction or Disappointment with T&CM Use | Country |
---|---|---|---|---|---|---|---|
Asuzu et al, 2017,24 | (a) Cross-sectional study. N = 400 patients Female = 76.2% (n=305); Mean age = 50.9±14.6 years; (b) Focus Group Discussions (FGD) Cancer sites: Various cancers including breast (33.5%) and cervix (32.5%). |
Prevalence use = 34.5% No results of disclosure or nondisclosure |
Not reported | Desire to be healed and get rid of pains, Recommendations by friends and relatives, Orthodox medicine expensive and no provisions for delayed or part payment; Perceived attacks from the devil or evil spirits causing illness, Fear of surgery, Unawareness about the illness, Breakdown of facilities |
Not reported | T&CM not effective reported by 70.1% of users. No particular side effects or perceived risks reported in the study. |
Nigeria |
Ezeome et al, 2007,3 | Cross-sectional study. N = 160 patients Female = 57.5% (n=94) Mean age = 52.3 years Cancer sites: Various cancers. |
Prevalence use = 65.0% (n=104) Disclosed use = 32.7% |
Herbs (51.9%) Healing prayers (39.4%) Aloe vera (23.1%) Forever living products (16.3%) Meditation (6.7%) Python fat (7.7%) Black stone (12.5%) Medicinal tea (14.4%) Special diet (6.7%) Chinese medicines (8.7%) |
Directly treat/cure cancer, Do something to the cancer, Improve physical wellbeing, Improve psychological and emotional wellbeing. |
Use associated with: Male sex, No association with: Age, Marital status, Level of education, Religion and Cancer site. |
Specific benefits: No benefits reported by 63.4% (n=70); 79.8% would not want to use T&CM again. 23.1% (n=26) were satisfied with T&CM use and 16.3% would recommend T&CM use. Side effects 21.2% reported side effects including slimming, weakness, malaise, generalized body discomfort, diarrhea, and cough. |
Nigeria |
Aliyu et al, 2017,48 |
Cross-sectional survey. N = 240 patients. Females = 56.2% Mean age = 45±13.7 years Cancer types: Various including cervical cancer (33.3%), Breast (22.1%), and Head/neck cancers (15.8%) |
Prevalence = 66.3% (159/240) Disclosed use = 15.3% |
Prayers = 30.8% (n=49) Herbal medicines = 28.3% (n=45) Scarification = 10.0% (n=17) |
Potentiate conventional cancer treatment 37.1% (n=59) More affordable = 18.9% (n=30) Readily available = 25.1% (n=40) Reduces nausea and vomiting = 11.9% (n=19) |
Use associated with: Male sex (OR=1.83; 95% CI: 1.02 – 3.25), and Absence of comorbidities (OR=0.32; 95% CI: 0.18 – 0.57). |
Benefits: 64.2% reported no benefits from use. Improved appetite (10.1%, n=16) Reduced pain (6.9%, n=11) Adverse reactions: Users reported Diarrhea (44.2%, n-106) Nausea and Vomiting (52.5%, n=126) Itching (30.4%, n=73) Skin rashes (9.3%, n=22) Headaches (7.1%, n=17) |
Nigeria |
Yarney et al, 2013,25 |
Cross-sectional survey. N = 98 patients. Females = 51%. Mean age = 55.5±17.1 years. |
Prevalence use = 73.5% Disclosed use = 16.7%. |
Massage = 66.3% Herbal = 59.2% Mega vitamins = 55.1% Chinese medicines = 53.1% Prayer = 42.9% |
Try anything = 31.2% Faith/beliefs = 21.9% Sickness is spiritual = 15.6% Toxicity of conventional treatment = 9.4% Conventional doctors are mechanical to the patient = 12.5% Disappointed with conventional treatment = 9.4% |
Use associated with: Young age, Being married, Higher level of education, Being female, Undergoing palliative care. No association with: Sex and cancer site. |
Benefits Fight cancer = 40.6% Relieve severity of the cancer = 23.2% Relaxation or sleep = 17.4% Improve emotional and physical well-being = 14.5% Adverse effects: Gastric upset Nausea and vomiting Diarrhea Itching Headaches |
Ghana |
Kiwanuka et al, 2018,26 | Cross-sectional study. N = 235 patients Breast cancer only Female only |
Prevalence use = 77% | Herbal = 22.0% Prayer = 20.0% Vitamins = 13.8% Native healers = 8.2% Chinese medicines = 5.5% |
Not reported | Use associated with: Dissatisfaction with conventional therapy (Odds ratio 2.15) | Not reported | Uganda |
Mwaka et al, 2019,27 | Cross-sectional study. N = 434 patients Female = 81.9% (352/) Mean age = 49.2±12.2 years Cancer sites: Breast (71.9%), Stomach (4.1%), Esophagus (8.3%), Colorectal (15.1%) |
Prevalence use = 55.6% Disclosed use = 38.7% |
Extracts from leaves = 45.4% Bottled mixed liquids = 43.3% Prayers = 28.8% Extracts from roots = 25.0% Dry power herbs = 17.9% Chinese medicines = 10.4% |
Cure cancer = 68.3% Improve immunity = 35.6% Relieve pain = 31.2% Reduce cancer symptoms = 19.5% Treat side effects of chemotherapy = 16.8% Prevent cancer = 8.6% Potentiate chemotherapy = 6.6% |
Use associated with: Advanced stage cancer, Being divorced or separated, No association with: Sex, age, education, and cancer site. |
No report on perceived benefits, risks or side effects of T&CM | Uganda |
Kiraki et al, 2019,42 |
Cross-sectional study. N = 117 patients Female= 53.8% Age: ≥16 years Cancer sites: Various including breast (13.7%) and cervix (12.8%) |
Prevalence use = 47.9% Disclosed use = 85.7% |
Spiritual therapy (37.5%, n=21) Vitamins and supplements (26.5%, n=15) Herbs (19.6%, n=11) Chinese herbs (12.5%, n=7) |
Cure of cancer = 78.6% Improve immunity = 44.6% Relieve cancer symptoms = 44.6% Manage pain = 23.2% |
No association with: Age, education, total household income, marital status, religion, residence. |
Benefits: Improved health (53.6%) Improved ability to cope (28.6%) Side effects No T&CM user reported adverse effects |
Kenya |
Aziato et al, 2015,49 | Exploratory qualitative study. N = 12 patients All female Age: 31 – 60 years Cancer site: Breast |
Prevalence of use = 33.3% | Prayers = 8.3% Herbs = 25.0% |
Avoid mastectomy | Not applicable | Benefits: Preserved femininity and sex life Avoid ridicule from men Side effects No report on perceived adverse effects of T&CM |
Ghana |
Erku et al, 2016,23 | Cross-sectional study. N = 195 Female = 54.3% Age: ≥18 years Cancer sites: Various including breast (37.9%) |
Prevalence of use = 79.0% Disclosed use = 20.8% |
Herbs = 72.1% Special foods = 38.9% Spiritual healing = 36.4% Dietary supplements = 22.1% |
Belief in advantages = 73.4% Dissatisfaction with conventional therapy = 14.9% Family tradition = 13.0% Emotional support = 11.0% Boost immunity = 8.4% |
Use associated with: Higher income, Tertiary education, Presence of comorbidity, Advanced stage cancer. |
Benefits: 49.3% (n=76) reported satisfaction with use 9.7% (n=15) were dissatisfied with use Adverse effects: 81.8% (n=126) of users reported no adverse effects from T&CM. |
Ethiopia |
Ong’udia et al, 2019,40 |
Cross-sectional study. N = 78 patients Female = 55.1% Age: ≥18 years Cancer site: Various including breast (29.5%) |
Prevalence of use = 14.1% Disclosed use = 55.0% |
Herbs = 91.0% Faith healing = 54.5% Divination = 36.3% Massage = 27.3% |
Restore hope = 73.0% Psychological comfort = 82.0% Increase quality of life = 82.0% Boost immunity = 73.0% Cure of disease = 64% Symptoms relief = 36% |
No association with: Age, Sex, Education, Marital status, Religion, Level of income. |
Benefit: 54.5% (n=5) of users satisfied with T&CM use 55.0% disappointed with use because use did not meet their expectations. 72% (n=8) of users would not recommend use. Side effects 27.0% (n=3) of users reported vomiting and urinary frequency |
Kenya |
Nwankwo et al, 2019,50 | Cross-sectional study. N = 95 patients Female = 100.0% Mean age = 50.9±11 years Cancer sites: Gynecological including cervix (44.2%) and ovary (32.6%). |
Prevalence use = 64.3% | Herbs = 73.8% | Not reported | Use associated with: Longer time to diagnosis, Longer duration of illness symptoms, Monthly income less than expenditure. |
Not reported | Nigeria |
De Boer et al, 2014,41 |
Cross-sectional study N = 161 patients Female = 31.1% Mean age = 34.0±7.7 years Cancer type: Kaposi sarcoma (100%) |
Prevalence use = 25.5% | Not reported | Not reported | Use associated with: Longer diagnostic delay (OR = 2.69 (95%CI: 1.17 – 6.17) |
Not reported | Uganda |
Note: a Reported percentages ≥5%.